medsafe.govt.nz/profs/datasheet/p/Propeciatab.pdf
Sorry but it does have to be downloaded.
There have been no label changes in this country to include depression, persistant ed etc. Infact if your lucky you still may see it being advertised on television.
Up until 2006 the rally of New Zealand was called “The propecia rally of New Zealand”. They chose not to renew in 2007 …
File a lawsuit.
Wow…
I am really confused this information is present on the above document :
"The following adverse experiences have been reported in postmarketing use: ejaculation disorder; breast tenderness and enlargement; depression; hypersensitivity reactions including rash, pruritus, urticaria, and swelling of the lips and face; testicular pain.
In addition, the following have been reported in post-marketing use: persistence of erectile dysfunction after discontinuation of treatment with PROPECIA; male breast cancer (see Warnings and Precautions)."
But none of this writting is present on the inbox ticket which i got with the drug.
They changed the label.
There has also been an update on the prescription information, ready for this fellas, the changes to the New Zealand Prescribing info have been highlighted in red (by me). This is different from the inbox leaflet, for some reason this is hidden from the consumer.
[Size=4]Post-marketing experience[/size]
The following additional adverse experiences have been reported in postmarketing use. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate the frequency or establish a causal relationship to drug exposure.
Immune system disorders: hypersensitivity reactions including rash, pruritus, urticaria, and swelling of the lips and face.
Psychiatric disorders: depression
Reproductive system and breast disorders: ejaculation disorder; breast tenderness and enlargement; depression; hypersensitivity reactions including rash, pruritus, urticaria, and swelling of the lips and face; testicular pain; erectile dysfunction that continued after discontinuation of treatment; male infertility and/or poor seminal quality. Normalization or improvement of seminal quality has been reported after discontinuation of finasteride.
This is getting out of hand.
